mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma']
more encouraging data at #asco23 on personalized neoantigen therapy in melanoma with over 60% reduction in distant metastasis free survival. presented by adnan khattak from perth. 
Executive Director, VCCC Alliance: alliance of 10 research, clinical & academic institutions working together to control & cure cancer